SEC Form 4 · accession 0001209191-15-023962
SALIX PHARMACEUTICALS LTD · SLXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy J Creech
Officer — See Remarks
Period of report
Mar 6, 2015
Accepted (ET)
Mar 9, 2015 · 1:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001009356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 6, 2015 | G | 500 | $0.00 | D | 30,037 | D | |
| Common Stock | Mar 6, 2015 | S | 4,600 | $157.6671 | D | 25,437 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Senior Vice President, Finance and Administrative Services, and Acting Chief Financial Officer